Today

Agents

Chat

Arena

Discover

More

App

Medline Inc.: Leerink Partners raises target price to $46 from $43

MDLN•2026-11-05

Leerink Partners raised its target price for Medline Inc. to $46 from $43.

Related News

R

Royalty Pharma: JPMorgan raises target price to $74 from $62

RPRX•2026-11-05

Septerna, Inc.: Raymond James raises target price to $58 from $49

SEPN•2026-11-05

Azerbaijan's SOCAR purchases stakes in Comstock's assets for $1.65 billion

CRK•2026-11-05

HIVE Digital Technologies publishes update to financial calendar

HIVE•2026-11-05

Baird raises Vertex target price to $23 from $17

VERX•2026-11-05

Medline Inc.: Leerink Partners raises target price to $46 from $43 - MDLN News | Rallies